Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Veracyte, Inc. (VCYT)  
$20.12 0.91 (4.33%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 82,823,000
Market Cap: 1.67(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $18.92 - $29.92
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  484
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Veracyte is a genomic diagnostics company. Co. develops tests that address clinical needs in the diagnosis, prognosis and treatment of cancer and other diseases. Co. provides tests in: thyroid cancer via its Afirma Genomic Sequencing Classifier (GSC) and Xpression Atlas; prostate cancer via its Decipher Biopsy and Radical Prostatectomy Genomic Classifiers; breast cancer via its Prosigna Breast Cancer Assay; lung cancer via its Percepta GSC and Percepta Nasal Swab Test; interstitial lung diseases including idiopathic pulmonary fibrosis via its Envisia Genomic Classifier; bladder cancer via its Decipher Bladder Genomic Classifier; and colon cancer via its Immunoscore Colon Cancer Test.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 60,000
Total Buy Value $0 $0 $0 $980,094
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 20,000 20,000 104,169 535,146
Total Sell Value $460,127 $460,127 $2,968,197 $14,025,264
Total People Sold 2 2 4 8
Total Sell Transactions 2 2 12 30
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 524
  Page 9 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ho Mark Principal Accounting Officer   •       •      –    2020-11-11 4 S $45.00 $624,375 D/D (13,875) 19,086 -2%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 GA $0.00 $0 I/I 45,812 47,906     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 GD $0.00 $0 D/D 45,812 174,419     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 OE $40.99 $849,929 D/D 20,000 220,231     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-11-10 4 OE $8.86 $177,200 D/D 20,000 240,231     -
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-06 4 AS $43.40 $923,106 D/D (21,250) 74,309 21%     
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-06 4 OE $20.21 $429,463 D/D 21,250 95,559     -
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-05 4 AS $40.00 $260,651 D/D (6,406) 74,309 19%     
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-11-05 4 OE $5.98 $47,902 D/D 6,406 80,715     -
   Ho Mark Principal Accounting Officer   •       •      –    2020-10-20 4 OE $6.45 $48,375 D/D 7,500 32,961     -
   Cohen Fred E Director   •       •      –    2020-10-19 4 OE $7.60 $76,000 D/D 10,000 10,000     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-10-08 4 AS $38.00 $1,900,000 D/D (50,000) 220,231 89%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-10-08 4 OE $8.86 $443,000 D/D 50,000 270,231     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-10-06 4 AS $35.21 $88,025 D/D (2,500) 79,399 111%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-10-06 4 OE $20.21 $50,525 D/D 2,500 81,899     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-09-10 4 AS $30.61 $617,861 D/D (20,000) 220,231 83%     
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-09-10 4 OE $8.86 $177,200 D/D 20,000 240,231     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-09-04 4 AS $30.05 $218,564 D/D (7,027) 79,399 68%     
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-09-04 4 OE $5.98 $49,618 D/D 6,479 86,426     -
   Kennedy Keith COO / CFO   •       •      –    2020-09-02 4 D $34.16 $38,635 D/D (1,131) 119,061     -
   Kennedy Giulia C Chief Scientific & Med Officer   •       •      –    2020-09-02 4 D $34.16 $18,446 D/D (540) 79,947     -
   Ho Mark Principal Accounting Officer   •       •      –    2020-09-02 4 D $34.16 $5,226 D/D (153) 25,461     -
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-09-02 4 D $34.16 $11,102 D/D (325) 74,309     -
   Anderson Bonnie H Chairman and CEO   •       •      –    2020-09-02 4 D $34.16 $67,500 D/D (1,976) 220,231     -
   Hanna John Walter Jr Chief Commercial Officer   •       •      –    2020-08-31 4 AS $33.37 $1,883,550 D/D (56,443) 74,634 50%     
  524 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us